These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 20804896)

  • 41. [New aspects in the classification of cutaneous lymphomas].
    Erós N; Károlyi Z; Kovács A
    Orv Hetil; 2001 Feb; 142(8):393-8. PubMed ID: 11263077
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Aggressive primary cutaneous B-cell lymphomas and novel EBV+ entities].
    Lamos C; Dippel E
    Hautarzt; 2017 Sep; 68(9):727-739. PubMed ID: 28815289
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Complete remission of a primary cutaneous B-cell lymphoma of the lower leg by first-line monotherapy with the CD20-antibody rituximab.
    Bonnekoh B; Schulz M; Franke I; Gollnick H
    J Cancer Res Clin Oncol; 2002 Mar; 128(3):161-6. PubMed ID: 11935303
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Primary cutaneous marginal zone B-cell lymphoma: An atypical case.
    Velázquez D; de Pablo P; García D; Ramírez JR
    Dermatol Online J; 2010 Dec; 16(12):5. PubMed ID: 21199631
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Cutaneous lymphomas. Quality Assurance Committee of the German Society of Dermatology and the Professional Organization of German Dermatologists e. V].
    Dummer R
    Hautarzt; 1998 Oct; 48 Suppl 1():S49-55. PubMed ID: 9866049
    [No Abstract]   [Full Text] [Related]  

  • 46. Primary cutaneous large B-cell lymphoma, leg type, presented with a migratory lesion.
    Ekmekci TR; Koslu A; Sakiz D; Barutcuoglu B
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):1000-1. PubMed ID: 17659027
    [No Abstract]   [Full Text] [Related]  

  • 47. Cutaneous B-cell lymphomas: 2013 update on diagnosis, risk-stratification, and management.
    Wilcox RA
    Am J Hematol; 2013 Jan; 88(1):73-6. PubMed ID: 23379008
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Febrile cellulitis surrounding a scar revealing a large immunoblastic B-cell lymphoma].
    Charavin-Cocuzza M; Templier I; Simon A; Salameire D; Cuchet E; Reymond JL; Beani JC; Leccia MT
    Ann Dermatol Venereol; 2008 Dec; 135(12):848-51. PubMed ID: 19084696
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Primary cutaneous B-cell lymphoma treated with radiotherapy: a comparison of the European Organization for Research and Treatment of Cancer and the WHO classification systems.
    Smith BD; Glusac EJ; McNiff JM; Smith GL; Heald PW; Cooper DL; Wilson LD
    J Clin Oncol; 2004 Feb; 22(4):634-9. PubMed ID: 14966086
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cutaneous lymphomas.
    Smith BD; Wilson LD
    Semin Radiat Oncol; 2007 Jul; 17(3):158-68. PubMed ID: 17591562
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Cutaneous follicular center B-cell lymphoma treated with intralesional rituximab].
    Gamo R; Calzado L; Pinedo F; López-Estebaranz JL
    Actas Dermosifiliogr; 2008 May; 99(4):291-6. PubMed ID: 18394405
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Systemic therapy of primary cutaneous B-cell lymphoma, marginal zone type, with rituximab, a chimeric anti-CD20 monoclonal antibody.
    Soda R; Costanzo A; Cantonetti M; Orlandi A; Bianchi L; Chimenti S
    Acta Derm Venereol; 2001; 81(3):207-8. PubMed ID: 11558880
    [No Abstract]   [Full Text] [Related]  

  • 53. Gigantic cutaneous lymphoma following Di Bella's therapy.
    Bassan R; Reseghetti A; Cortelazzo S; Rossi A; Buelli M; Viero P; Barbui T
    Haematologica; 2002 Apr; 87(4):EIM13. PubMed ID: 11940500
    [No Abstract]   [Full Text] [Related]  

  • 54. Cutaneous B-cell lymphomas: 2019 update on diagnosis, risk stratification, and management.
    Wilcox RA
    Am J Hematol; 2018 Nov; 93(11):1427-1430. PubMed ID: 30039522
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reduction of tumor burden and stabilization of disease by systemic therapy with anti-CD20 antibody (rituximab) in patients with primary cutaneous B-cell lymphoma.
    Heinzerling LM; Urbanek M; Funk JO; Peker S; Bleck O; Neuber K; Burg G; von Den Driesch P; Dummer R
    Cancer; 2000 Oct; 89(8):1835-44. PubMed ID: 11042581
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intralesional and intravenous treatment of cutaneous B-cell lymphomas with the monoclonal anti-CD20 antibody rituximab: report and follow-up of eight cases.
    Kerl K; Prins C; Saurat JH; French LE
    Br J Dermatol; 2006 Dec; 155(6):1197-200. PubMed ID: 17107389
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Two pediatric cases of primary cutaneous B-cell lymphoma and review of the literature.
    Sharon V; Mecca PS; Steinherz PG; Trippett TM; Myskowski PL
    Pediatr Dermatol; 2009; 26(1):34-9. PubMed ID: 19250402
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Primary lymphoma of the central nervous system located in the cerebellum].
    Castro-Bouzas D; Prieto-González Á; Allut AG; Serramito-García R; Gelabert-González M
    Rev Neurol; 2012 Aug; 55(4):251-3. PubMed ID: 22829089
    [No Abstract]   [Full Text] [Related]  

  • 59. Evaluation of B-cell clonality using the BIOMED-2 PCR method effectively distinguishes cutaneous B-cell lymphoma from benign lymphoid infiltrates.
    Morales AV; Arber DA; Seo K; Kohler S; Kim YH; Sundram UN
    Am J Dermatopathol; 2008 Oct; 30(5):425-30. PubMed ID: 18806482
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Treatment of indolent cutaneous B‑cell lymphoma].
    Wobser M
    Hautarzt; 2017 Sep; 68(9):721-726. PubMed ID: 28766120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.